Login to Your Account



Licensing a Mainstay of 2013 Biotech Deal-Making

By Marie Powers
Staff Writer

Monday, August 19, 2013

Biopharma deal-making returned to the fore during the first half of 2013, with 368 licenses and joint ventures (JV) compared to 265 during the first six months of 2012 – a 39 percent surge, according to Thomson Reuters Recap. All told, Recap captured 1,234 life science deals during the first half of the year, with licenses and JVs representing 30 percent of the total.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription